Navigation Links
Milestone Scientific Announces 2010 Year End Results
Date:4/4/2011

-controlled drug delivery technologies for the medical and dental markets; and currently sells its award-winning products through a global distribution network serving North and South America, Asia, Africa and Europe. For more information on the STA System and other innovative Milestone products, please visit the Company's websites found at www.milestonescientific.com and www.STAis4u.com.

Safe Harbor StatementThis press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2009. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.FOR MORE INFORMATION, PLEASE CONTACT:Milestone Scientific Inc.Joseph D'Agostino, Chief Financial OfficerFor Media Inquiries: Laura Kaunitz, Office M
'/>"/>

SOURCE Milestone Scientific Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Callisto Reports on Second-Quarter 2007 Milestones
2. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
3. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
4. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
5. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
6. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
7. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
8. Medarex to Receive Milestone Payment from Amgen
9. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
10. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
11. Bionomics Achieves US$1 Million Milestone Payment from Genmab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Research and Markets has ... Market (Technology, Types, Applications, Services and Geography) - ... their offering. A new report ... - Size, Share, Global Trends, Company Profiles, Demand, ... 2013 - 2020", suggests that the global biosimilars ...
(Date:8/20/2014)... 20, 2014 Research and Markets  has announced ... report to their offering. Global Market ... on Pralmorelin globally and regionally ( Europe , ... , Latin America etc.). It captures ... This report focuses on three primary areas; manufacture methods & ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
Breaking Medicine Technology:Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... Dec. 29, 2010 Reportlinker.com announces that a ... catalogue: The Market for Pharmaceuticals ... http://www.reportlinker.com/p0203101/The-Market-for-Pharmaceuticals-in-Brazil-Russia-India--China.html Evaluate the ... Brazil, Russia, India and China now and in ...
... Dec. 29, 2010 Centocor Ortho Biotech Inc. announced ... Application (sBLA) with the U.S. Food and Drug Administration ... treatment of moderately to severely active ulcerative colitis (UC) ... to conventional therapy.  REMICADE was designated orphan drug status ...
Cached Medicine Technology:Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 2Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 3Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 4Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 5Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 2Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 3Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 4Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 5Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 6
(Date:8/20/2014)... Gray HealthDay Reporter WEDNESDAY, ... rare, colds, flu and other minor infections might trigger a ... children, a new study suggests. Just five out of ... States, said Dr. Heather Fullerton, lead author of the study ... of California, San Francisco Benioff Children,s Hospital. "It seems infections ...
(Date:8/20/2014)... August 20, 2014 The Board of ... Perkins Eastman is pleased to announce the expansion ... in China and the surrounding region. In ... Richard Sprow AIA has relocated to the firm’s ... in healthcare planning and design and to better support ...
(Date:8/20/2014)... With 3943.8% growth, Connexion Point ranks number 86 ... growing companies. The Inc. 500 ranks Connexion Point 12th, nationally, ... is the #1 fastest growing company in Utah. , Connexion ... its clients include four of the top 10 health care ... has offices and contact centers in Salt Lake City, Provo, ...
(Date:8/20/2014)... In contrast to evidence that the amygdala stimulates ... Primate Research Center, Emory University have found that ... hormones during the early development of nonhuman primates. ... Journal of Neuroscience . , The amygdala ... be important for responses to threatening situations and ...
(Date:8/20/2014)... New research reveals that, long ago, sea mammals may ... the infectious disease known as tuberculosis. Ancient strains ... and sea lions, who then spread it to people ... an international team of researchers. "Tuberculosis is a ... study and further research will help us understand how ...
Breaking Medicine News(10 mins):Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2Health News:Maturing brain flips function of amygdala in regulating stress hormones 2Health News:Maturing brain flips function of amygdala in regulating stress hormones 3Health News:Seals, Sea Lions Helped Global Spread of TB, Study Finds 2
... 12 /Xinhua-PRNewswire-FirstCall/ -- China,Medicine Corporation ("CMC") ... of prescription and over the counter ... made of Chinese herbs),Chinese herbs, nutritional ... formulations today announced the Company,s ADTZ,(Aflatoxin-detoxifizyme) ...
... reveal more damage compared to sporadic cases , FRIDAY, Oct. ... appears to cause more severe brain damage than the non-familial ... scans to examine the brains of 759 MS patients and ... more destructed lesions, and significantly lower volume of whole brain, ...
... for lowering cholesterol and maybe even fighting dementia, and ... slow decline in lung function in the elderly even ... it may be statins anti-inflammatory and antioxidant properties that ... in the second issue for October in the American ...
... WESTFIELD, N.J., Oct. 12 Don,t hire an ad agency; ... great marketing,ideas. It is not because an agency can,t come ... options to uncover new marketing ideas. Most clients follow ... out an RFP, interview agencies, then develop a,short list of ...
... CHICAGO, Oct. 11 Continuing its efforts ... SAVE THE PATIENT, a,not-for-profit patient-focused organization, is hosting ... Network. "Community Health Hotline" will,air Monday, October 15, ... Monday,s program will feature a frank discussion on ...
... 11 /Xinhua-PRNewswire/ -- On,October 10, 2007, Synutra International, ... of dairy-based nutritional products,for infants, children and adults, ... that the Company,s common stock is no longer ... on October 5, 2007 of the,Company,s quarterly report ...
Cached Medicine News:Health News:China Medicine's ADTZ Project Has Been Selected as One of Six Patent Commercialization Projects in Guangdong Province 2Health News:Familial MS May Be More Destructive 2Health News:Statins reduce loss of function, keeping old lungs young - even in smokers 2Health News:A New Way to Discover Marketing Ideas 2Health News:Patient Empowerment -- Medication Error 2Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2
Inquire...
Inquire...
Contour I pouches are light as a feather and feature our tapered SoftFlex skin barrier for comformability, flexbility and comfort. All Contour I pouches have ComfortWear panels that keep skin cool an...
Inquire...
Medicine Products: